Dergiler / Turkish Journal of Anaesthesiology and Reanimation / 2018 / Cilt: 46 - Sayı: 3

Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1

Sayfa
165–167
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BILOTTA, F., GIORDANO, G., CAROLETTI, F., PUGLIESE, F. (2018). Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 46 - Sayı: 3, 165–167. https://ajindex.com/articles/370185

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Kostrzewska E. Blood substitutes. Ann R Coll Surg Engl 1976; 58: 115-25.
  2. Hartog CS, Natanson C, Sun J, Klein HG, Reinhart K. Concerns over use of Hydroxyethyl starch solutions. Brit Med J 2014; 349: g5981. Available from: https://www.regulations.gov/document?D=FDA- 2017-P-0867-0001 (accessed May 3, 2018). Solanke TF. Clinical Trial of 6% Hydroxyethyl starch (a New Plasma Expander). Brit Med J 1968; 3: 783-78. [CrossRef ] Alexander B, Odake K, Lawlor D, Swanger M. Coagulation, hemostasis, and plasma expanders: a quarter century enigma. Fed Proc 1975; 34: 1429-40. Strauss RG. Review of the effects of Hydroxyethyl starch on the blood coagulation system. Transfusion 1981; 21: 299-302. [CrossRef ] Haynes GR, Havidich JE, Payne KJ. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 2004; 101: 560-1. [CrossRef ] Waldhausen P, Kiesewetter H, Leipnitz G, Scielny J, Jung F, Bambauer R, et al. Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage. Acta Med Austriaca 1991; 18(Suppl 1): 52-5.
  3. Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-9. [CrossRef ] Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2. [CrossRef ] Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39. [CrossRef ] Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-34. [CrossRef ] Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or Saline for Fluid Resuscitation in Intensive care. N Engl J Med 2012; 367: 1901-11. [CrossRef ] Wise J. Boldt: the great pretender. Brit Med J 2013; 346: f1738. Tramèr MR. The Boldt debacle. Eur J Anaesthesiol 2011 28: 393-5.
  4. Zarychanski R, Abou-Setta A, Turgeon A, Houston BL, McIntyre L, Marshall JC, et al. Association of Hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation a systematic review and meta-analysis. JAMA 2013; 309: 678-88. [CrossRef ] Antonelli M, Sandroni C.